Biofil Chemicals & Pharmaceuticals Ltd. (BSE: 524396) is a Indore, Madhya Pradesh-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹49 Cr, it ranks #3,881 by market cap among the 6,137 Indian listed companies on FinBizNet, and #77 of 86 in Medicinal Chemicals and Botanical Products. At ₹28.86 (as of 25 Oct 2026), the share price is 37.7% below its 52-week high of ₹46.34 and 12.7% above its 52-week low of ₹25.60. The share price is down 28.4% over one year and down 10.0% over three months.
| Current Price | ₹28.86 |
|---|---|
| Market Cap | ₹49 Cr |
| BSE Code | 524396 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 17.4 |
| Return on Equity | 13.83% |
| Return on Assets | 0.66% |
| 52-Week Range | ₹25.60 – ₹46.34 |
| 1-Year Price Change | -28.4% |
| 3-Month Price Change | -10.0% |
| Beta (1Y) | 0.45 |
| Headquarters | Indore, Madhya Pradesh |
| Website | www.biofilgroup.net |
| Revenue | ₹12 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 0.9% |
| EPS (Basic) | ₹0.07 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.
1. Pharma Division-This segment manufactures and sells pharmaceutical products. 2. Chemicals Division-This segment manufactures and sells chemicals. 3. Other-0 4. Segment Adjustment-0
1. Pharma Division-66.8% 2. Chemical Division-33.2%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Biofil Chemicals & Pharmaceuticals Ltd. | ₹49 Cr | 17.4 | 13.83% | ₹12 Cr | -28.4% |
Listed by market capitalisation. Ratios are shown for context only.
Biofil Chemicals & Pharmaceuticals Ltd. is trading at ₹28.86, with a market capitalisation of ₹49 Cr.
Biofil Chemicals & Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Biofil Chemicals & Pharmaceuticals Ltd. has a P/E of 17.4 and a return on equity of 13.83%.
Biofil Chemicals & Pharmaceuticals Ltd. is listed on the BSE under the scrip code 524396.
Biofil Chemicals & Pharmaceuticals Ltd.'s share price is down 28.4% over one year and down 10.0% over three months. Its 52-week range is ₹25.60 to ₹46.34.
In Q1 FY27, Biofil Chemicals & Pharmaceuticals Ltd. reported revenue of ₹12 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.07 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.